secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001708599-25-000013
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics closes $5M second tranche of equity financing at 113% premium
--------------------------------------------------------------------------------

- Received second $5M tranche of $10M equity financing from JuvVentures (UK) Limited.
- Issued 500,000 shares at $10/share (113% premium to Jan 31 close of $4.70).
- Issued warrants for 755,728 shares at $18.00 per share.
- Funds to advance SER-252 (POZ-apomorphine) into Phase 1 trial in advanced Parkinson's in H2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000013/0001708599-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000013/ser-20250203.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer